About US
Contact us
-
GlaxoSmithKline signs manufacture deal with Samsung BiologicsGlaxoSmithKline has signed an agreement with South Korea-based Samsung Biologics for additional capacity to manufacture and supply its biopharmaceutical therapies. According to the terms of the deal,2020/5/22
-
AstraZeneca gets $1bn from US BARDA to support Covid-19 vaccineUK-based pharmaceutical company AstraZeneca has received more than $1bn from the US Biomedical Advanced Research and Development Authority (BARDA) to develop, manufacture and deliver a Covid-19 vacci2020/5/21
-
Bharat Biotech and Thomas Jefferson partner on Covid-19 vaccineIndia-based Bharat Biotech hasentered into an exclusive agreement to develop a Covid-19 vaccine candidate created at Thomas Jefferson UniversityinPhiladelphia, US. Infectious Diseases expert professo2020/5/21
-
Roche enters $135m drug discovery deal with Vividion TherapeuticsRoche has signed an exclusive worldwide option and licence agreement with US-based biotechnology firm Vividion Therapeutics to discover and develop small molecules for various therapeutic targets. Un2020/5/20
-
UK provides funding support for Covid-19 vaccine programmeThe UK Government has committed to providing £84m in funding and manufacturing support to researchers working on Covid-19 vaccine programme, said Business Secretary Alok Sharma. Of the total funding,2020/5/20
-
AstraZeneca gets breakthrough status for Enhertu to treat NSCLCAstraZeneca and its partner Daiichi Sankyo have received breakthrough therapy designation (BTD) from the US Food and Drug Administration (FDA) for Enhertu (trastuzumab deruxtecan) to treat non-small2020/5/19
-
Phlow secures $354m US contract for drug supply amid Covid-19US-based public benefit drug manufacturing corporation Phlow has received$354m funding from the government to produce essential medicines at risk of shortage amid the Covid-19 pandemic. The contract2020/5/19
-
J&J signs Covid-19 vaccine manufacturing contract with VibalogicsJohnson & Johnson (J&J) has signed a deal with contract development and manufacturing organisation (CDMO) Vibalogics for the manufacture of clinical trial material for a Covid-19 vaccine cand2020/5/18
-
Novartis’ AveXis gets EC conditional approval for ZolgensmaNovartis subsidiary AveXis has received conditional approval from the European Commission (EC) for Zolgensma (onasemnogene abeparvovec) to treat spinal muscular atrophy (SMA). The approval is for inf2020/5/18
-
Merck's Keytruda thumped SeaGen's Adcetris in a head-to-head trial. How much does it matter?Merck’s Keytruda has taken on the standard of care in classical Hodgkin lymphoma and won. But with a closely watched combination making its way through the clinic,how long will the results be relevan2020/5/15